TheEdgeResearch
Home / Stocks / PXYN

Praxsyn Corporation (PXYN)

OTC Healthcare Medical - Pharmaceuticals
$0.00 ▲ +0.00%
Market Cap
$6,347
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
0.80
52-Wk Range
0.000001-0.00001
CEO
Sean Daly
Country
US
Currency
USD

Praxsyn Corporation operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Scottsdale, AZ, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $6,347. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of -695.5%. Its beta of 0.80 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.01
Price / Sales
0.08
Price / Book
0.00
EV / EBITDA
-11.85
Gross margin
29.4%
Operating margin
-240.9%
Net margin
-695.5%
Return on equity
—
Debt / equity
0.65
Current ratio
1.28
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
66
IPO date
2010-08-16
Headquarters
Scottsdale, AZ, US
About Praxsyn Corporation

Praxsyn Corporation operates as a healthcare enterprise, supplying medical professionals with specific medications and related services for their patients. The company specializes in creating non-narcotic and non-habit-forming treatments, utilizing therapeutic and preventative compounds. These come in various formats, such as transdermal creams, patches, and oral capsules, and are formulated to treat issues like pain management, erectile dysfunction, and metabolic disorders. Praxsyn's offerings are available to patients covered by California's workers' compensation program, along with those under preferred provider contracts. Established in 2005, the company was formerly known as The PAWS Pet Company, Inc. before changing its name to Praxsyn Corporation in March 2014. Its operations are based out of Las Vegas, Nevada.

Comparable companies

Praxsyn Corporation is most often compared with the following Healthcare names:

DNAGIMMBIPAHJNHMFLRDSFMHTXRBIIREFGSPPHUSRM
More research on PXYN
PXYN technical analysis PXYN TheEdge Score Compare against peers
Open full interactive analysis & DCF →